Andrew Thompson is Scientific Director of Life Science at synchrotron SOLEIL and responsible for the overall coordination of the role of SOLEIL. Andrew joined SOLEIL in 2002 to handle the creation of PROXIMA1. He also closely monitored the set-up of PROXIMA2, the second bio-crystallography beamline at SOLEIL, as a technical advisor, and was the director of the biology scientific section at SOLEIL for two years.